Kyriakopoulos, C., Chen, Y., Jeraj, R., Duan, F., Tripathi, A., Kosoff, D., Garje, R., Pachynski, R. K., Parikh, R. A., Harzstark, A., Adra, N., Maughan, B. L., Zakharia, Y., Corn, P. G., Liu, G., Carducci, M. A., Luo, J., Antonarakis, E. S. (2025). CTC and AR-V7 analysis in the ECOG-ACRIN 8153 (CHAARTED2) randomized trial: Abiraterone (Abi) with or without cabazitaxel (Abi-Cabazi) in extensive mCRPC following docetaxel.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.181